Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Georgia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Georgia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Georgia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Alexander Bottini (NPI 1033505086)

Field	Value
Entity Type	Individual
Organization	Alexander Bottini
Address	1255 Friendship Rd Ste 160
City	Braselton
State	GA
ZIP	30517
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	April 7, 2015

Payer Source	Total Paid
Medicare	$3M
Medicaid	$0

Key Findings

This provider is effectively single‑payer from a claims perspective: Total Medicare revenue is $3M while Total Medicaid revenue is none (no Medicaid billing on file), indicating Medicare drives the entire recorded public‑payer footprint and reimbursement mix. That concentration has implications for network leverage and patient access strategies that will be heavily Medicare‑focused.

Revenue is highly concentrated in three injectable retinal drugs: J2777 ($1.1M, 37.5%), J0178 ($1.1M, 35.2%), and J2778 ($364K, 12.0%), which together account for 84.7% of this provider's total Medicare revenue. This top‑3 concentration (84.7%) signals a business model that depends on high‑value ophthalmic drug administration rather than diversified service lines.

Clinical/service mix aligns with retina specialty procedural care: the top revenue drivers are intravitreal injections (J2777, J0178, J2778) consistent with chronic retinal disease management, while procedure codes such as 67028 (1.8K claims, $169.1K, 5.6%) document numerous isolated intravitreal injection procedures and 92134 (2.6K claims, $78.3K, 2.6%) reflects heavy retinal imaging to support treatment decisions. Together these codes suggest a practice workflow centered on repeated, image‑guided intravitreal therapy and follow‑up.

Competitive standing on the national stage is mixed: J2777 activity ranks #172 of 2039 (92th percentile) and J0178 ranks #775 of 3204 (76th percentile), indicating typical but solid national volumes for these drug administrations rather than top‑tier dominance. J2778 ranks #214 of 1208 (82th percentile), similarly reflecting above‑average but not exceptional national presence for that agent.

There are notable statistical outliers in diagnostic and evaluation codes that point to unusually high ancillary service volume: 92134 is labeled an extreme outlier (98th percentile) with 2.6K claims and $78.3K in revenue, and 99204 is also an extreme outlier (100th percentile) with 324 claims and $38.9K in revenue. Elevated 92134 imaging volumes combined with frequent higher‑level new patient E/Ms suggest the provider either sees a high throughput of complex retinal cases or relies heavily on imaging to manage treatment protocols.

Procedure and laser services supplement the injection workload: 67145 shows notably above typical national volume (97th percentile) with 54 claims and $8.3K revenue, and 67228 and 92250 appear with smaller revenue contributions ($7K and $7.6K respectively). These entries imply the practice performs a nontrivial amount of laser and fundus photography in addition to injections, consistent with a comprehensive retina care offering.

Routine office evaluation codes contribute only modestly to revenue relative to drug receipts: 92014 (699 claims, $59.4K, 2.0%) and 92012 (564 claims, $36.1K, 1.2%) together provide a small share of Medicare revenue compared with the high dollar injectable codes. This pattern is consistent with a procedure‑heavy, treatment‑driven revenue model where high‑cost biologic injections dominate reimbursement.

The provider has an established billing history with NPI enumerated on 2015‑04‑07 (~11 years ago), and the combination of $3M in lifetime Medicare revenue and concentrated anti‑VEGF/faricimab and aflibercept billing positions them as an established retina specialist in their market. Given the absence of Medicaid billing, payers and network analysts should treat this entity as Medicare‑centric when modeling referral volumes, utilization patterns, and contract negotiations.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

16 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	39,180	$30	$1.1M
J0178	Injection, aflibercept, 1 mg	1,560	$680	$1.1M
J2778	Injection, ranibizumab, 0.1 mg	2,020	$180	$364K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,820	$90	$169.1K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,610	$30	$78.3K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	700	$90	$59.4K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	320	$120	$38.9K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	560	$60	$36.1K
J3490	Unclassified drugs	20	$1,760	$28.1K
J9035	Injection, bevacizumab, 10 mg	300	$60	$16.4K

Showing 1–10 of 16

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Georgia Distribution

Alexander Bottini — 3 of 16 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Georgia

Full comparison — all codes billed, vs. state median

16 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	12	70	970	$680	$700.6K
J2777	4	40	14,100	$30	$524.3K
J2778	9	30	1,170	$180	$286.2K
67028	5	80	720	$90	$71.9K
J3490	50	50	50	$320	$19.8K
92014	76	850	130	$80	$19.7K
92012	28	380	90	$60	$10.5K
J9035	12	70	120	$50	$10.3K
92134	8	620	70	$30	$7.1K
67228	3	10	20	$240	$6.6K

Showing 1–10 of 16

Related Providers

Other providers that share a Tax Identification Number (TIN) with Alexander Bottini, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Stephanie Vanderveldt	GA	Ophthalmology Physician	$4.1M	$0
Ajey Alurkar	PA	Ophthalmology Physician	$4.1M	$0
Sri Krishna Mukkamala	GA	Hospitalist Physician	$3.4M	$0
David Chin Yee	GA	Retina Specialist (Ophthalmology) Physician	$2.9M	$0
Gregory Lee	GA	Ophthalmology Physician	$2.9M	$6.3K
Robert Stoltz	GA	Specialist	$2.6M	$0
Hyung Cho	GA	Ophthalmology Physician	$2.5M	$0
Sean Koh	GA	Ophthalmology Physician	$2.5M	$0
Atul Sharma	GA	Ophthalmology Physician	$2.2M	$0
Mark Rivellese	GA	Ophthalmology Physician	$2.1M	$0

Nearby Providers

Other providers in the same ZIP code as Alexander Bottini, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Susan Oh	GA	Dermatology Physician	$616.1K	$0
Georgia Interventional Pain - B LLC	GA	Ambulatory Surgical Clinic/Center	$368.1K	$0
Olufemi Aina	GA	Hospitalist Physician	$267.3K	$0
Stephen Prater	GA	Clinical Cardiac Electrophysiology Physician	$246.2K	$0
Anointed Hands Medical Service	GA	Family Medicine Physician	$0	$241.5K
Darrell Scales	GA	Orthopaedic Surgery Physician	$208.6K	$0
Richard Burgner	GA	Diagnostic Radiology Physician	$201.4K	$0
Ryan Whitney	GA	Cardiovascular Disease Physician	$201K	$0
Prasad Garimella	GA	Critical Care Medicine (Internal Medicine) Physician	$192.3K	$0
Naga Kommuri	GA	Cardiovascular Disease Physician	$188.1K	$0

Alexander Bottini — Billing Profile & Reimbursement Data

Sign up for Alexander Bottini — Billing Profile & Reimbursement Data policy alerts

Alexander Bottini — Billing Profile & Reimbursement Data

Sign up for Alexander Bottini — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References